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Salmonellae are facultative intracellular bacteria capable of surviving within macrophages. Salmonella
pathogenicity island 2 (SPI-2) is required for growth within macrophages and for virulence in mice. In this
study, we show the involvement of SPI-2 in a signal transduction pathway that induces cytokine expression in
Salmonella-infected macrophages. High levels of interleukin-10 (IL-10) mRNA were induced in macrophages by
infection with wild-type salmonellae compared to a strain carrying a mutation in the spiC gene, which is
encoded within SPI-2. The two strains had the same effect on the expression of proinflammatory cytokines such
as IL-1, IL-6, and tumor necrosis factor alpha. IL-10 expression was dose dependently blocked by treatment
of infected macrophages with the protein kinase A (PKA) inhibitor H-89, while IL-10 expression was increased
by the PKA activator dibutyryl cyclic AMP. Cyclic AMP-dependent PKA activity was higher in macrophages
infected with wild-type salmonellae compared to the spiC mutant, and Ser132 phosphorylation of cyclic AMP
response element-binding protein (CREB), which is an important mediator of PKA activation, correlated with
the levels of PKA activity. Taken together, these results indicate that salmonellae cause an SPI-2-dependent
increase in PKA activity that leads to CREB phosphorylation, resulting in up-regulation of IL-10 expression
in Salmonella-infected macrophages. Suppression of IL-10 expression by an antisense oligonucleotide did not
affect the growth of wild-type salmonellae within macrophages, whereas growth was dose dependently inhibited
by H-89, suggesting that the PKA signaling pathway plays a significant role in intramacrophage Salmonella
survival.
Macrophages are essential to defense mechanisms against
many infections. A number of cytokines are known to affect the
function of macrophages. Gamma interferon (IFN-), pro-
duced by antigen-specific helper T cells, activates macrophages
(33, 34), and this activation is critical for the host defense
against intracellular pathogens that can survive within macro-
phages (5, 22, 46). Macrophage functions may, however, be
blocked by interleukin-4 (IL-4), IL-10, and transforming
growth factor beta (7, 8, 36, 38, 50). In particular, IL-10, which
is a well-characterized anti-inflammatory cytokine (30, 32, 43),
can inhibit the production of reactive oxygen intermediates
(ROI) and reactive nitrogen intermediates (RNI) in activated
macrophages (7, 21), and macrophages are a major source of
IL-10 production. Some intracellular pathogens, including sev-
eral Salmonella spp., Mycobacterium spp., Legionella pneumo-
phila, and Listeria monocytogenes, target macrophages as a site
of infection. Some of these intracellular pathogens have been
reported to use IL-10 to survive within macrophages or to
inhibit the host defense by deactivating macrophages in murine
models of infection (1, 4, 12, 14, 16, 21, 39, 47). Thus, IL-10
appears to play a role in creating a favorable environment for
intracellular pathogens within macrophages.
Salmonellae invade and destroy specialized epithelial cells
(M cells) in the host’s intestine; migrate to the mesenteric
lymph nodes, where they encounter macrophages; and subse-
quently survive and replicate within infected macrophages.
Specific virulence factors encoded within Salmonella pathoge-
nicity islands (SPI) are required at various stages of Salmonella
infection (23). SPI-1, located at centisome 63 on the Salmo-
nella enterica serovar Typhimurium chromosome, is required
for salmonellae to enter epithelial cells (18, 19) and to promote
apoptosis in macrophages (26). In addition, Hobbie et al. (27)
reported that proteins secreted by the type III secretion system
encoded within SPI-1 can trigger host cell signal transduction
pathways that activate transcription factors NF-B and AP1.
This activation induces production of proinflammatory cyto-
kines such as IL-8, which are presumably important in the
inflammatory diarrhea that follows Salmonella infection.
SPI-2, which is a 40-kb pathogenicity island located at cen-
tisome 30.7 on the S. enterica serovar Typhimurium chromo-
some, is required for the ability to grow within mammalian
cells, such as macrophages or epithelial cells, and is required
for virulence in mice (11, 23, 24, 25, 35, 45). Previous work
showed that a mutant defective in the spiC gene, which lies
adjacent to the spiR (ssrA)/ssrB two-component regulatory
genes within SPI-2, was unable to survive within macrophages
and unable to inhibit fusion between Salmonella-containing
vacuoles (SCV) and lysosomal and endosomal compartments
(48). SpiC protein is translocated into the cytosol of infected
macrophages by the type III secretion system in SPI-2. Lee et
al. (29) further reported that the SpiC protein interacts with a
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host protein homologous to the family of NIPSNAP proteins,
which may be involved in intracellular vesicular trafficking.
However, other researchers showed that SpiC is required for
the translocation of SPI-2 effector proteins into target cells (15,
51). Thus, more research is needed to clarify the molecular
function of SpiC. Recent studies (10, 20, 49) have shown that
SPI-2 is required to inhibit fusion of SCV with vesicles of the
endocytic pathway, such as inducible nitric oxide synthase-
containing vesicles. SPI-2 is also involved in inhibiting recruit-
ment of NADPH oxidase components to the phagosome.
These observations indicate that a role of SPI-2 is to interfere
with intracellular vesicular trafficking to avoid exposure to
toxic agents such as ROI and RNI in infected macrophages.
In this study, we analyzed cytokine expression in Salmonella-
infected macrophages to examine the mechanisms by which
SPI-2 promotes intramacrophage survival and show the in-
volvement of SPI-2 in Salmonella-induced expression of IL-10
in macrophages. Salmonellae cause an SPI-2-dependent in-
crease in PKA activity that leads to cyclic AMP (cAMP)
response element-binding protein (CREB) phosphorylation,
resulting in up-regulation of IL-10 expression in Salmonella-
infected macrophages. In addition, we discuss the roles of
endogenous IL-10 and the PKA signaling pathway in intra-
macrophage survival of salmonellae. This is the first report that
SPI-2 affects a signal transduction pathway that induces cyto-
kine expression.
MATERIALS AND METHODS
Reagents. Reagents for cell culture were purchased from Sigma (St. Louis,
Mo.), and other reagents were purchased from the following sources: H-89 was
from Seikagaku (Tokyo, Japan); PD98052, SB203580, and GF109203X were
from Calbiochem (La Jolla, Calif.); SP600125 and dibutyryl cAMP (dbcAMP)
were from Biomol (Plymouth Meeting, Pa.); and recombinant murine IFN- was
from PharMingen (San Diego, Calif.). H-89, PD98052, SB203580, GF109203X,
and dbcAMP were dissolved in dimethyl sulfoxide (DMSO). When these drugs
were used, the final concentration of DMSO in the culture medium was 0.1%;
this concentration of solvent did not affect the cell responses.
Bacterial strains and growth conditions. The strains used in this study were
derived from wild-type S. enterica serovar Typhimurium strain 14028s. The
spiC::kan derivative EG10128 and purB::Tn10 strain EG9652 were described by
Uchiya et al. (48). Bacteria were grown at 37°C in Luria broth (LB). Kanamycin
and tetracycline were used at 50 and 15 g/ml, respectively.
Macrophage survival assay. The murine macrophage cell line Raw264.7 was
maintained in a 37°C incubator with 5% CO2 in Dulbecco’s modified Eagle’s
medium supplemented with 10% heat-inactivated fetal calf serum (HyClone,
Logan, Utah), 100 U of penicillin per ml, and 100 g of streptomycin per ml. On
the day before infection, the macrophages were plated at a density of 1.0 
106/well in 6-well tissue culture plates (Falcon) or 0.4  106/well in 24-well plates
in medium without antibiotics. The macrophage survival assay was conducted as
described previously (48). A multiplicity of infection of 25 bacteria per macro-
phage was used.
Semiquantitative reverse transcription (RT)-PCR and Northern blot analysis.
Total RNA was extracted from macrophages in six-well plates infected with
bacteria (1:25) by using RNAzol B (TEL-TEST, Friendswood, Tex.) in accor-
dance with the protocol recommended by the manufacturer and then digested
with DNase I (Stratagene). RNA (2 g) was reverse transcribed with SuperScript
II reverse transcriptase (Life Technologies, Rockville, Md.) by using an oligo
(dT) primer. PCR was conducted in 20-l reaction mixtures consisting of reac-
tion buffer (Perkin-Elmer, Forester City, Calif.), 0.5 M deoxynucleoside
triphosphate, each primer at 1 M, 1 l of cDNA, and 1 U of Taq DNA
polymerase (Perkin-Elmer) in cycles of 94°C for 1 min, 55°C for 1 min, and 72°C
for 1 min. Amplification was carried out for 30 cycles for IL-1, 35 cycles for
IL-6, 25 cycles for IL-10, 30 cycles for IL-12, 20 cycles for tumor necrosis factor
alpha (TNF-), and 17 cycles for -actin, followed by a 7-min final extension at
72°C. In each case, the number of amplification cycles achieved exponential
amplification, in which product formation was proportional to the starting cDNA
(data not shown). The PCR products were subjected to electrophoresis in a 1.5%
agarose gel and visualized by ethidium bromide staining. Visual analysis and
image-analyzing software (Gel-Doc 2000 System; Bio-Rad, Hercules, Calif.)
were used for comparison of band intensities. The primer pairs were as follows:
IL-1, 5-CTC TAG AGC ACC ATG CTA CAG-3 and 5-TGG AAT CCA
GGG GAA ACA CTG-3 (309-bp fragment); IL-6, 5-TGG AGT CAC AGA
AGG AGT GGC TAA-3 and 5-TCT GAC CAC AGT GAG GAA TGT
CCA-3 (155-bp fragment); IL-10, 5-TAC CTG GTA GAA GTG ATG CCC-3
and 5-CAT CAT GTA TGC TTC TAT GCA-3 (252-bp fragment); IL-12(p40),
5-CGT GCT CAT GGC TGG TGC AAA-3 and 5-CTT CAT CTG CAA GTT
CTT GGG-3 (314-bp fragment); TNF-, 5-GGC AGG TCT ACT TTG GAG
TCA-3 and 5-ACA TTC GAG GCT CCA GTG AAT-3 (300-bp fragment);
-actin, 5-TGG AAT CCT GTG GCA TCC ATG AAA-3 and 5-TAA AAC
GCA GCT CAG TAA CAG TCC-3 (350-bp fragment).
For Northern blot analysis of IL-10 mRNA, 20 g of total RNA was electro-
phoresed in a 1% formaldehyde-agarose gel and transferred to nylon membranes
(Duralon-UV; Stratagene) in 10 SSC buffer (1 SSC is 0.15 M NaCl plus 0.015
M sodium citrate). The 32P-labeled probes for IL-10 and glyceraldehyde 3-phos-
phate dehydrogenase (GAPDH) were incubated with the filters for 18 h at 42°C,
followed by two washes with 2 SSC containing 0.1% sodium dodecyl sulfate
(SDS) at 37°C for 15 min. Final washes were carried out at 55°C for 15 min with
0.2 SSC containing 0.1% SDS. Bands were visualized by autoradiography and
analyzed with a GS-800 calibrated densitometer (Bio-Rad). The probe for IL-10
corresponds to bases 1 to 636 of the murine IL-10-coding region. GAPDH was
used as an internal standard for quantification of total RNA in each lane of the
gel.
Quantification of IL-10. The amount of IL-10 present in culture supernatants
was determined by a murine IL-10 capture enzyme-linked immunosorbent assay
(ELISA) with IL-10-specific MAb (monoclonal antibody [Ab]) JES3-9D7 as the
capture Ab and biotinylated anti-IL-10 MAb JES-12G8 as the detection Ab
(PharMingen). The assay was performed in accordance with the manufacturer’s
recommendations and standardized with murine recombinant IL-10 (Phar-
Mingen). The sensitivity of the IL-10 ELISA was 10 pg/ml.
Western blot analysis. Macrophages in six-well plates were changed to serum-
free medium and then 5 h later were infected with bacteria (1:25). At the
indicated times postinfection, the cells were washed twice with phosphate-buff-
ered saline and homogenized in lysis buffer (50 mM Tris-HCl [pH 7.5], 1%
Triton X-100, 1 mM EDTA, 1 mM NaF, 1 mM sodium orthovanadate, 1 mM
phenylmethylsulfonyl fluoride, 20 M leupeptin, 20 M aprotinin), and protein
concentrations were determined with a protein assay kit (Bio-Rad) with bovine
serum albumin as the standard. Total proteins (50 g) were fractionated in
SDS–10% polyacrylamide gels and then electrotransferred to a polyvinylidene
difluoride membrane (Millipore, Bedford, Mass.). After blocking with Tris-
buffered saline containing 3% bovine serum albumin and 0.05% Tween 20, the
membranes were incubated sequentially with primary Ab and horseradish per-
oxidase-conjugated secondary Ab. Bands were detected by chemiluminescence
(ECL; Amersham Pharmacia Biotech) and analyzed with a GS-800 calibrated
densitometer. Phosphorylation of p38 mitogen-activated protein kinase (MAPK)
and CREB was determined with the PhosphoPlus p38 MAPK (Tyr182) and
PhosphoPlus CREB (Ser132) kits from New England Biolabs (Beverly, Mass.),
respectively.
PKA assay. Protein kinase A (PKA) activation was assayed as described by
McKenzie and Pouyssegur (31), with minor modifications. After infection with
bacteria, the cells were washed twice with cold phosphate-buffered saline and
scraped in a buffer (50 mM Tris-HCl [pH 7.5], 0.25 M sucrose, 5 mM EDTA, 10
mM EGTA, 1 mM phenylmethylsulfonyl fluoride, 20 M leupeptin, 20 M
aprotinin, 50 M -glycerophosphate, 200 M sodium orthovanadate, 50 mM
NaF). The scraped cells were sonicated and centrifuged at 100,000 g for 30 min
at 4°C. After determination of protein concentrations, the supernatants were
assayed for PKA activity with Kemptide (Sigma) as the substrate. Total PKA
activity was measured in the presence of 10 M cAMP. PKA activity was calcu-
lated from the difference in ATP incorporation in the absence or presence of 1
M PKA inhibitor peptide (Calbiochem) and expressed as a percentage of the
total PKA activity.
Transfection with oligonucleotides (ODNs). An antisense ODN (AS-ODN;
nucleotide positions 637 to 654) directed against the sequence of murine IL-10
mRNA and a corresponding sense ODN (S-ODN) were synthesized, and trans-
fections of macrophages with ODNs were conducted as described previously (2).
Statistical analysis. Each experiment was performed at least three times. The
results are expressed as means 	 standard deviations (SD). Data on inhibitor
effects on macrophage survival were analyzed with the unpaired two-tailed Stu-
dent t test, and other data were analyzed by analysis of variance with Dunnett’s
test. A P value of 
0.05 was considered statistically significant.
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The spiC and purB mutants are defective for intramacro-
phage survival. We previously reported that a strain carrying a
nonpolar mutation in the spiC gene is defective for intramac-
rophage survival when assayed at 18 h postinfection (48). In
this study, we examined in detail the levels of intramacrophage
survival of wild-type, spiC mutant, and purB mutant salmonel-
lae at 2.5, 5, and 10 h after infection with the macrophage-like
cell line Raw264.7. The purB mutant, which is deficient in
purine metabolism, is known to be defective for intramacro-
phage survival (6). As shown in Fig. 1, the level of intramacro-
phage survival of both spiC and purB mutants was about 50%
of the wild-type level at 2.5 h postinfection. At 5 h postinfec-
tion, survival of the spiC mutant was unchanged, but that of the
purB mutant was 30% of the wild-type level. At 10 h postin-
fection, the levels of the spiC and purB mutants were about 40
and 5% of the wild-type level, respectively. Because the spiC
mutant is less defective in intramacrophage survival than is the
purB mutant, the purB mutant can serve as a control to test
whether spiC defects result simply from poor intramacrophage
survival.
Expression of cytokine mRNAs in macrophages infected
with salmonellae. We next examined cytokine expression in
macrophages infected with wild-type, spiC mutant, and purB
mutant salmonellae. Expression was analyzed by RT-PCR of
total RNA extracted from macrophages at 5 h postinfection.
As shown in Fig. 2, the level of IL-10 mRNA was lower in spiC
FIG. 1. Salmonella growth levels within macrophages. Raw264.7
macrophages in 24-well tissue culture plates were infected at a ratio of
10 bacteria per cell, centrifuged, and incubated for 20 min to permit
phagocytosis. Macrophages were lysed at 0, 2.5, 5, and 10 h and plated
onto LB agar to determine the number of viable bacteria. For each
mutant, the percent survival relative to that of the wild-type strain
(100%) is presented. Data presented are the mean and SD of three
independent experiments.
FIG. 2. Expression of cytokine mRNAs in macrophages infected with salmonellae. (A) At 5 h postinfection with wild-type (WT), spiC mutant,
or purB mutant salmonellae, total RNA extracted from the pooled macrophages was reverse transcribed into cDNA and amplified by PCR with
primer pairs specific to each cytokine. The PCR products were run on 1.5% agarose gels. (B) Expression of cytokines, normalized to actin
expression. Data are the mean and SD of three independent experiments. The spiC mutant IL-10 level is significantly lower than that of wild-type
salmonellae. *, P 
 0.001 compared to macrophages infected with wild-type salmonellae. UI, uninfected.
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mutant-infected macrophages than in wild-type-infected mac-
rophages. The purB mutation did not affect IL-10 levels, indi-
cating that the lower level of IL-10 expression induced by spiC
mutant salmonellae is due to defective SpiC function and is not
a result of reduced replication within macrophages. On the
other hand, the levels of IL-12(p40) expression induced by the
spiC and purB mutants were lower than that induced by wild-
type salmonellae, indicating that IL-12(p40) expression is de-
pendent on the level of intracellular proliferation of salmonel-
lae. The expression of proinflammatory cytokines IL-1, IL-6,
and TNF- showed no difference following infection with wild-
type salmonellae and the spiC mutant, suggesting that the spiC
gene could be specifically influencing the signal transduction
pathway involved in IL-10 expression.
Up-regulation of IL-10 expression is dependent on SPI-2.
To confirm the RT-PCR analysis results, IL-10 mRNA in Sal-
monella-infected macrophages was quantified by Northern blot
analysis. The expression of IL-10 mRNA in wild-type Salmo-
nella-infected macrophages at 2.5 h postinfection was in-
creased 1.4-fold compared with that in spiC mutant-infected
macrophages (Fig. 3A). At 5 h postinfection, the difference in
IL-10 mRNA expression was 2.5-fold. In accord with the RT-
PCR analysis results, the purB mutant induced the same levels
of IL-10 expression as did the wild type.
We next used an ELISA to examine the levels of IL-10 in
culture supernatants of Salmonella-infected macrophages. As
shown in Fig. 3B, IL-10 production increased during the course
of infection. IL-10 levels were higher in macrophages infected
with wild-type salmonellae or with the purB mutant than in
those infected with the spiC mutant up to 10 h postinfection.
At 20 h postinfection, however, IL-10 production in wild-type
Salmonella-infected macrophages was threefold higher than
that in spiC or purB mutant-infected macrophages, presumably
because the purB mutant had little or no capacity to survive
within macrophages at 20 h postinfection. These results show
that the spiC gene is involved in the up-regulation of IL-10
production in Salmonella-infected macrophages.
Raw264.7 macrophages were used in this study because the
levels of IL-10 expression in Raw264.7 macrophages infected
with salmonellae were higher than those in J774 macrophages
or in peritoneal macrophages obtained from female BALB/c
mice. Nevertheless, the three types of macrophages had the
same pattern of IL-10 expression after infection with wild-type,
spiC mutant, or purB mutant salmonellae (data not shown).
Involvement of PKA and p38 MAPK in Salmonella-induced
expression of IL-10. To understand the signal transduction
pathways involved in Salmonella-induced expression of IL-10,
we tested the effects of several protein kinase inhibitors on
IL-10 induction. As shown in Fig. 4A, IL-10 production in
wild-type Salmonella-infected macrophages was dose depen-
dently blocked by the PKA inhibitor H-89 or the p38 MAPK
inhibitor SB203580. In contrast, addition of the extracellular
signal-regulated protein kinase 1 and 2 (ERK1/2) inhibitor
PD98052, the PKC inhibitor GF109203X, or the JNK inhibitor
SP600125 did not inhibit IL-10 production (data not shown).
These results indicate that both the PKA and p38 MAPK
signaling pathways could participate in Salmonella-induced ex-
pression of IL-10. To examine further the involvement of PKA
in IL-10 production, we used an activator of PKA, dbcAMP.
The level of IL-10 production was increased 16-fold when
FIG. 3. IL-10 expression in macrophages infected with salmonellae. (A) Northern blot analysis of IL-10 mRNAs in macrophages infected with
wild-type (WT), spiC mutant, or purB mutant salmonellae. At 2.5 and 5 h postinfection, total RNA was extracted as described in Materials and
Methods, run on 1.5% agarose gels, transferred to membranes, and hybridized with 32P-labeled DNA probes for IL-10 and GAPDH. The results
of one of three experiments performed are presented. (B) Time course studies of Salmonella-induced IL-10 production by macrophages.
Macrophages were infected with wild-type, spiC mutant, or purB mutant salmonellae. At the time points indicated, supernatants were harvested
and tested for IL-10 content by ELISA. The inset shows the result at 20 h postinfection. Data are the mean and SD of three independent
experiments. The spiC mutant IL-10 level is significantly lower than that of wild-type salmonellae. *, P 
 0.001 compared to macrophages infected
with wild-type salmonellae. UI, uninfected.
VOL. 72, 2004 INVOLVEMENT OF PKA IN SPI-2 FUNCTION 1967
 o
n
 January 29, 2014 by W







Salmonella-infected macrophages were treated with 1.0 mM
dbcAMP (Fig. 4B), whereas treatment of uninfected macro-
phages with dbcAMP had no effect on IL-10 production. These
results show that up-regulation of IL-10 in Salmonella-infected
macrophages may depend on the activation of PKA.
Salmonellae induce SPI-2-dependent PKA activation, re-
sulting in up-regulation of IL-10 expression. To examine the
roles of p38 MAPK and PKA in Salmonella-mediated IL-10
induction, the levels of p38 MAPK phosphorylation and PKA
activity were measured. p38 MAPK was assayed by Western
blotting with phosphospecific antibodies. As shown in Fig. 5,
infection with wild-type salmonellae increased p38 MAPK
phosphorylation. The increase was detectable 1 h postinfec-
tion, and by 5 h postinfection, phosphorylation levels were
1.9-fold higher than in uninfected cells. At 10 h postinfection,
the levels of p38 MAPK phosphorylation in Salmonella-in-
fected macrophages returned to the basal level (data not
shown). In contrast, the phosphorylation levels in spiC and
purB mutant-infected macrophages were only slightly in-
creased compared with those in uninfected macrophages, but
there was no significant difference between the two mutant
strains during the course of infection. Together with results
obtained with the p38 MAPK inhibitor, these results indicate
that, although p38 MAPK is involved in Salmonella-induced
expression of IL-10, the increase in p38 MAPK phosphoryla-
tion is a result of the increased intracellular proliferation of
wild-type salmonellae and may not depend on SpiC function.
PKA activity in wild-type Salmonella-infected macrophages
was higher than that in uninfected macrophages (Table 1). In
contrast, the levels of PKA activity in spiC mutant-infected
macrophages were the same as those in uninfected macro-
phages. In addition, purB mutant-infected cells displayed wild-
type levels of PKA activity up to 5 h postinfection, indicating
that activation of PKA in wild-type Salmonella-infected mac-
rophages depends on SpiC function.
Since the spiC gene is involved in PKA activation, it was of
interest to assay the phosphorylation of CREB. The catalytic
subunit of activated PKA can phosphorylate CREB in the
nucleus, which regulates the ability of CREB to activate tran-
scription. Platzer et al. (40) reported that the IL-10 promoter
contains a cAMP response element, where CREB binds,
strongly suggesting that the phosphorylation of CREB is im-
portant for IL-10 expression. Thus, we measured the phos-
phorylation of CREB at Ser133 by Western blot analysis. As
shown in Fig. 6, increased levels of CREB phosphorylation in
Salmonella-infected macrophages were first observed at 2.5 h
postinfection, and the elevation continued at 5 h. At 10 h
postinfection, CREB phosphorylation returned to the basal
level (data not shown). The purB mutant showed the same
effect on CREB phosphorylation as the wild type. The spiC
mutant, however, induced approximately 1.4-fold lower CREB
phosphorylation at 2.5 and 5 h postinfection. Taken together,
these results demonstrate a role for the spiC gene in the acti-
vation of PKA, but not p38 MAPK, that leads to the phos-
phorylation of CREB, resulting in increased IL-10 production
in Salmonella-infected macrophages.
The PKA signaling pathway plays a significant role in the
intramacrophage survival of salmonellae. Having shown that
salmonellae significantly induce production of IL-10 from mac-
rophages, we tested whether increased IL-10 production is
important for intramacrophage survival of salmonellae. For
this purpose, an AS-ODN complementary to IL-10 mRNA was
used to inhibit IL-10 production; a corresponding S-ODN
served as a control. As shown in Fig. 7A, treatment with the
FIG. 4. Involvement of PKA and p38 MAPK in Salmonella-induced IL-10 production by macrophages. (A) Effects of inhibitors of PKA (H-89),
ERK1/2 (PD98052), and p38 MAPK (SB203580) on Salmonella-induced production of IL-10. Macrophages were infected with wild-type salmo-
nellae, and an inhibitor at the indicated concentrations or a 0.1% DMSO solvent control was added simultaneously. At 18 h postinfection,
supernatants were harvested and tested for IL-10 by ELISA. The graph shows percent IL-10 production by macrophages treated with inhibitors
compared to that in untreated macrophages. Data are the mean and SD of three independent experiments. Both H-89 and SB203580 caused a
significant reduction in the level of IL-10. *, P 
 0.01; #, P 
 0.005 (compared to macrophages treated with 0.1% DMSO solvent). (B) Effect of
a PKA activator (dbcAMP) on Salmonella-induced production of IL-10. Macrophages were infected with wild-type or spiC salmonellae, and
dbcAMP at the indicated concentrations or a 0.1% DMSO solvent control was added simultaneously. At 18 h postinfection, supernatants were
harvested and tested for IL-10 content by ELISA. The graph shows percent IL-10 production by macrophages treated with dbcAMP compared
to that by untreated macrophages. Data are the mean and SD of three independent experiments.
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AS-ODN (10 M) decreased IL-10 production in wild-type
Salmonella-infected macrophages to the level of IL-10 produc-
tion in spiC mutant-infected macrophages. However, suppres-
sion of IL-10 production by the AS-ODN had little effect on
the growth of wild-type salmonellae within macrophages (Fig.
7B). In addition, treatment of macrophages with recombinant
IL-10 at 1 to 10 ng/ml had no significant effect on the intra-
cellular growth of salmonellae (data not shown), indicating
that IL-10 may not be required to mediate the role of SPI-2 in
intramacrophage survival. To examine further the effect of
IL-10 on the intramacrophage survival of salmonellae, macro-
phages activated by recombinant IFN- were used. Treatment
with IFN- (10 to 1,000 U) significantly decreased the survival
level of wild-type salmonellae in macrophages treated with the
AS-ODN compared with that of macrophages treated with the
S-ODN (P 
 0.01 or P 
 0.005, Fig. 7C). This result suggests
that IL-10 could be inhibiting the cytotoxic mechanisms of
macrophages activated by IFN- and shows the possibility that
IL-10 plays an important role in the growth of salmonellae
within activated macrophages in murine Salmonella infection.
We next examined the influence of the PKA and p38 MAPK
signaling pathways on the intramacrophage survival of salmo-
nellae. As shown in Fig. 8, treatment with the p38 MAPK
inhibitor SB203580 had little inhibitory effect on the intracel-
lular growth of salmonellae, whereas growth was strongly de-
creased by treatment with the PKA inhibitor H-89 in a dose-
dependent manner. These results indicate that the PKA
signaling pathway plays a significant role in the intramacro-
phage survival of salmonellae and suggest that the role of SPI-2
in the intramacrophage survival of salmonellae is at least partly
mediated by the PKA signaling pathway.
DISCUSSION
Here we show the involvement of SPI-2 in the signal trans-
duction pathway that induces IL-10 expression in Salmonella-
infected macrophages. Salmonellae cause activation of the
PKA signaling pathway in a manner dependent on SPI-2, re-
sulting in up-regulation of IL-10 expression. In addition, we
also found that the PKA signaling pathway plays a significant
role in the intramacrophage survival of salmonellae.
Previous work has shown roles for SPI-2 in inhibiting fusion
of SCV with vesicles of the endocytic pathway, such as induc-
FIG. 5. Western blot analysis of phospho-p38 (pp-38) in macrophages infected with salmonellae. A Western blot analysis of cytosolic extracts
from macrophages infected with wild-type (WT), spiC mutant, or purB mutant salmonellae is shown. At the indicated times postinfection, cytosolic
extracts were prepared as described in Materials and Methods, run on an SDS–10% polyacrylamide gel, transferred to PVDF membranes, and
developed with anti-phospho-p38 and anti-p38 Abs. Panel A shows the original blots. After analysis with an anti-phospho-p38 Ab (top), the
membranes were stripped and reprobed with an Ab directed to p38 (bottom). (B) Densitometric analysis of the amount of phospho-p38 normalized
to the amount of p38 in the same sample. The graphs show percentages of the value in uninfected macrophages. Similar results were obtained in
three separate experiments. UI, uninfected.
TABLE 1. PKA activity in macrophages infected with salmonellaea
Strain used for infection
PKA activity (% of total)
2.5 h 5 h 10 h
None (uninfected control) 6.33 	 0.70 7.63 	 0.61 7.99 	 0.66
Wild type 10.59 	 0.26b 12.58 	 1.22b 11.90 	 0.38b
spiC mutant 7.12 	 0.57 6.42 	 1.74 8.32 	 0.74
purB mutant 9.42 	 0.24b 10.70 	 0.59b 9.46 	 0.48
a Macrophages were infected with wild-type, spiC mutant, or purB mutant
salmonellae for 2.5, 5, and 10 h. Cell lysates were prepared and assayed for PKA
activity as described in Materials and Methods. Results are expressed as the
mean 	 SD of three independent experiments.
b P 
 0.01 compared to macrophages infected with the spiC mutant.
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ible nitric oxide synthase-containing vesicles, and in inhibiting
recruitment of NADPH oxidase components to the phago-
some (10, 20, 48, 49). To examine the mechanisms by which
SPI-2 promotes intramacrophage survival of salmonellae, we
focused on the cytokines expressed in Salmonella-infected
macrophages, since a number of cytokines have been reported
to affect the function of macrophages. In particular, IL-10 is
known as a macrophage-deactivating factor, as are transform-
ing growth factor beta and IL-4. Park et al. (39) reported that
Legionella pneumophila, a facultative intracellular pathogen,
stimulates production of IL-10 in human alveolar macrophages
and blood monocytes, and IL-10 treatment enhances the
growth of L. pneumophila in monocytes. Moreover, IL-10 may
down-regulate the production of chemical mediators involved
in inflammation, such as nitric oxide and ROI (7, 21). Certain
viruses also can induce cellular IL-10 in macrophages (42, 44),
whereas other viruses encode their own IL-10 homologs (28).
Thus, IL-10 appears to create a favorable environment for
pathogen survival in macrophages. These observations
prompted us to examine the role of IL-10 in the intramacro-
phage survival of salmonellae. Unexpectedly, growth of salmo-
nellae within macrophages was not affected either by antisense
suppression of IL-10 production or by exogenously added IL-
10. However, in macrophages activated by recombinant IFN-,
the AS-ODN did inhibit the intracellular growth of salmonel-
lae. Taken together, these results indicate that IL-10 does not
directly mediate the role of SPI-2 in promoting intramacro-
phage survival of salmonellae. The results nevertheless raise
the possibility that IL-10 plays an important role in the estab-
lishment of systemic infection by blocking the cytotoxic mech-
anisms of activated macrophages. Indeed, Arai et al. (1)
showed that neutralization of endogenous IL-10 by anti-IL-10
MAb accelerates macrophage functions, enhancing the host
defense against murine Salmonella infection.
Our results showed that SPI-2 is involved in the up-regula-
tion of IL-10 expression in Salmonella-infected macrophages,
but it does not affect the expression of proinflammatory cyto-
kine IL-1, IL-6, or TNF-, suggesting that SPI-2 could influ-
ence the signal transduction pathway involved in IL-10 expres-
sion in macrophages. Therefore, we examined which signal
transduction pathways are involved in Salmonella-mediated
IL-10 induction. We found that inhibition of p38 MAPK and
PKA blocked this induction, supporting the involvement of
both the p38 MAPK and PKA signaling pathways in this pro-
cess. p38 MAPK is commonly activated by inflammatory cyto-
kines and stress stimuli (37). To examine further the role of
p38 MAPK in Salmonella-induced expression of IL-10, we
measured the phosphorylation of p38 MAPK. Wild-type sal-
monellae induced higher phosphorylation of p38 MAPK in
macrophages than did spiC mutant salmonellae, but there was
no significant difference between spiC mutant and purB mutant
salmonellae, which, like spiC salmonellae, are defective for
intramacrophage survival. The purB mutant thus tests whether
the results obtained are due to the levels of intracellular
growth of salmonellae or directly related to SpiC function. Our
results imply that although p38 MAPK is involved in Salmo-
nella-induced expression of IL-10, the increase in p38 MAPK
phosphorylation is a result of the increased intracellular pro-
FIG. 6. Western blot analysis of phospho-CREB (p-CREB) in macrophages infected with salmonellae. Macrophages were infected with
wild-type (WT), spiC mutant, or purB mutant salmonellae. At the indicated times postinfection, cytosolic extracts were prepared as described in
Materials and Methods, run on an SDS–10% polyacrylamide gel, transferred to PVDF membranes, and developed with anti-phospho-CREB and
anti-CREB Abs. Panel A shows the original blots. Following analysis with an anti-phospho-CREB Ab (top), the membranes were stripped and
reprobed with an Ab directed to CREB (bottom). (B) Densitometric analysis of amounts of phospho-CREB normalized to the amount of CREB
in the same sample. The graphs show percentages of the value in uninfected macrophages. Similar results were obtained in three separate
experiments. UI, uninfected.
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liferation of wild-type salmonellae and is not dependent on
SpiC function.
To confirm the involvement of the PKA signaling pathway in
Salmonella-induced expression of IL-10, we measured PKA
activity in infected macrophages. While wild-type salmonellae
increased PKA activity in infected macrophages, the spiC mu-
tant failed to induce any increase over the level in uninfected
cells. Results obtained with the purB mutant control indicated
that the increase in PKA activity depends on SpiC function and
that the up-regulation of IL-10 production induced by wild-
FIG. 7. Effects of AS-ODN directed against IL-10 mRNA on Salmonella survival within macrophages. (A) Effect of AS-ODN on IL-10
production. Macrophages were treated for 4 h with 10 M AS-ODN or S-ODN and then infected with wild-type (WT) salmonellae. At 18 h
postinfection, supernatants were harvested and tested for IL-10 by ELISA. Data are the mean and SD of three independent experiments. (B) Effect
of AS-ODN on Salmonella survival within macrophages. Macrophages were treated for 4 h with AS-ODN or S-ODN (10 M) and then infected
with wild-type salmonellae. Samples were taken at 18 h and plated onto LB agar to determine the number of viable bacteria. The percent survival
shown is relative to that of the wild-type strain within untreated macrophages. Data are the mean and SD of three independent experiments.
(C) Effect of AS-ODN on Salmonella survival within IFN--activated macrophages. Macrophages treated for 4 h with AS-ODN or S-ODN (10 M)
were infected with wild-type salmonellae, and IFN- at the indicated concentrations was added simultaneously. Samples were taken at 18 h and
plated onto LB agar to determine the number of viable bacteria. The percent intramacrophage survival shown is relative to that of the wild-type
strain within untreated macrophages. Data are the mean and SD of three independent experiments. AS-ODN caused a significant reduction on
Salmonella survival within macrophages. *, P 
 0.01; **, P 
 0.005 (compared to macrophages treated with S-ODN).
FIG. 8. Effects of SB203580 (a p38 MAPK inhibitor) and H-89 (a PKA inhibitor) on Salmonella survival within macrophages. Macrophages
were infected with the wild-type strain, and SB203580 (A) or H-89 (B) at the indicated concentrations or a 0.1% DMSO solvent control was added
simultaneously. Samples were taken at 0 and 18 h and plated onto LB agar to determine the number of viable bacteria. The percent survival shown
is relative to that of the wild-type strain within untreated macrophages. Data are the mean and SD of three independent experiments. H-89 caused
a significant reduction in Salmonella survival within macrophages. *, P 
 0.05; **, P 
 0.001 (compared to macrophages treated with 0.1% DMSO
solvent).
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type salmonellae could occur through the activation of PKA.
This conclusion is also supported by the fact that dbcAMP,
which stimulates the PKA enzyme directly, enhanced IL-10
production in Salmonella-infected macrophages. Indeed, PKA
activation leads to translocation of the catalytic subunit of PKA
enzyme to the nucleus, where the phosphorylation of CREB
takes place. A cAMP response element, where CREB binds, is
present in the promoter region of the gene for IL-10 (40).
Eigler et al. (13) reported that the activation of PKA by cAMP
enhances IL-10 production in peripheral blood monocytes.
Thus, since phosphorylation of CREB via PKA activation is
important for the up-regulation of IL-10 production, we mea-
sured the phosphorylation levels of CREB in Salmonella-in-
fected macrophages and found that they correlated with the
results of PKA activity.
Given our finding that activation of PKA by salmonellae is
dependent on SPI-2, we examined the role of the PKA signal-
ing pathway in the intramacrophage survival of salmonellae.
The intracellular growth of wild-type salmonellae was dose
dependently decreased by treatment with a PKA inhibitor,
suggesting that PKA activation could be a critical mechanism
that salmonellae exploit to survive within macrophages. This
conclusion is also supported by the following observations.
PKA down-regulates the activation of the NADPH oxidase
component p47phox in stimulated neutrophils, and it directly
phosphorylates Rap1A, a low-molecular-weight GTP-binding
protein (3, 17, 41). As phosphorylated Rap1A cannot bind to
the flavocytochrome b558 component of the NADPH oxidase
complex, no respiratory burst is elicited (9). Thus, PKA affects
components of the NADPH oxidase complex and reduces its
ability to produce superoxide radicals, indicating that PKA
plays a significant role in superoxide-dependent mechanisms
that kill ingested bacteria in phagocytes. Recent studies have
shown that one of the mechanisms by which SPI-2 promotes
the intramacrophage survival of salmonellae is interference
with intracellular vesicular trafficking so as to avoid exposure
to toxic agents such as ROI or RNI. To our knowledge, there
are no reports that describe the relationship between the PKA
signaling pathway and intracellular trafficking of vesicles.
Taken together, these facts suggest that, in addition to inhib-
iting intracellular vesicular trafficking, SPI-2 also inhibits su-
peroxide production by affecting components of the NADPH
oxidase complex on the membrane of SCV through the acti-
vation of PKA. However, more research is needed to clarify
the involvement of the PKA signaling pathway in the intram-
acrophage survival of salmonellae.
In conclusion, our study shows that Salmonella infection of
macrophages causes activation of the PKA signaling pathway
in a manner dependent on SPI-2, which leads to CREB phos-
phorylation and results in up-regulation of IL-10 expression.
Although the mechanism by which SPI-2 affects the PKA sig-
naling pathway remains unknown, our results show that this
pathway plays a significant role in the intramacrophage survival
of salmonellae.
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